 | ImmunityBio, Inc. | |||
| NMS : IBRX || Location: United States | ||||
$5.27+0.36 (+7.33%) |
4.55 M | 4.82 - 5.3 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 54.765 M |
| March 15, 2024 | 53.252 M |
| Feb. 29, 2024 | 51.547 M |
| Feb. 15, 2024 | 47.140 M |
| Jan. 31, 2024 | 43.934 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.18 | -0.35 | -90.63% |
| 09/30/2023 | -0.26 | -0.19 | 26.95% |
| 06/30/2023 | -0.24 | -0.32 | -33.50% |
| 03/31/2023 | -0.28 | -0.27 | 1.96% |
| 12/31/2022 | -0.22 | -0.27 | -20.32% |
IBRX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 677.003M | Shares Float | 145.270M |
| Short Float | 54.765M | Market Cap | 3324.08M |
| Institution ownership | 8.85% | Insider ownership | 79.618% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.97 | Forward EPS | -0.45 |